echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Gastric Cancer: Gastric cancer is very common in Lynch syndrome patients with atrophic gastritis

    Gastric Cancer: Gastric cancer is very common in Lynch syndrome patients with atrophic gastritis

    • Last Update: 2021-03-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Lynch syndrome (Lynch syndrome (LS)) is an inherited cancer susceptibility syndrome caused by mutations in four mismatch repair (MMR) genes: MLH1, MSH2, PMS2 and MSH6.

    This autosomal dominant genetic disease is characterized by an abnormally increased incidence of colorectal cancer (60-80%) and endometrial cancer (30-70%).
    At present, colorectal cancer in LS patients has several clinicopathological features, but It is not very clear.
    Therefore, in order to investigate the risk and clinicopathological characteristics of gastric tumors in LS, the researchers conducted a retrospective cohort study on Japanese LS patients.

    Researchers collected clinical data of LS patients with pathogenic mismatch repair (MMR) gene variants from the LS registry of the National Cancer Center Hospital of Japan, and then used the Kaplan-Meier method to estimate the cumulative risk of gastric tumors, including development The incidence of ill health and cancer.

    The condition of gastric atrophy was assessed by endoscopic and/or histological methods, and all available specimens were further analyzed by immunohistochemical staining of MMR protein.

    Of the 118 eligible LS patients, 26 patients were diagnosed with gastric tumors.

    At the age of 70, the cumulative incidence of gastric tumors was 41.
    0% (95% confidence interval 26.
    9-55.
    0).

    Among them, 13 patients (50%) developed multiple simultaneous and/or metachronous gastric tumors.

    Among the 49 types of gastric tumors that can be used for detailed pathological evaluation, all are related to intestinal metaplasia.

    Immunohistochemical analysis showed that 42 (86%) patients had MMR deficiency.

    Compared with patients without gastric atrophy, patients with gastric atrophy had a significantly higher risk of gastric tumors (26/54 vs.
    0/53) (P = 0.
    026).Through this retrospective study, the authors found that: for LS patients, especially patients with atrophic gastritis, the risk of gastric cancer is high, and it often develops into multiple tumors.

    For LS patients, especially patients with atrophic gastritis, it is recommended to conduct close endoscopic monitoring for gastric cancer.

     Original source: Hourin Cho.
    Et al.
    Gastric cancer is highly prevalent in Lynch syndrome patients with atrophic gastritis.
    Gastric Cancer.
    2021.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.